Trimolecular interactions in experimental autoimmune demyelinating disease and prospects for immunotherapy - PubMed (original) (raw)

Affiliations

PMID: 1718484

Review

Trimolecular interactions in experimental autoimmune demyelinating disease and prospects for immunotherapy

R B Bell et al. Semin Immunol. 1991 Jul.

Abstract

Experimental allergic encephalomyelitis (EAE) is a T cell mediated model of demyelinating disease that develops as a result of an autoimmune response to the myelin structural antigen, myelin basic protein (MBP). Much information has accumulated on the nature of trimolecular interactions which lead to the activation of self-reactive T lymphocytes in this disorder. Many parallels exist in the etiopathogenesis of EAE and multiple sclerosis (MS). Based upon these similarities selective immunotherapy that targets either class II molecules of the major histocompatibility complex or T cell receptor variable region genes will be described for EAE with consideration given to application of these principles in MS.

PubMed Disclaimer

Cited by

Protective autoimmunity is a physiological response to CNS trauma.
Yoles E, Hauben E, Palgi O, Agranov E, Gothilf A, Cohen A, Kuchroo V, Cohen IR, Weiner H, Schwartz M. Yoles E, et al. J Neurosci. 2001 Jun 1;21(11):3740-8. doi: 10.1523/JNEUROSCI.21-11-03740.2001. J Neurosci. 2001. PMID: 11356861 Free PMC article.
The human myelin basic protein gene is included within a 179-kilobase transcription unit: expression in the immune and central nervous systems.
Pribyl TM, Campagnoni CW, Kampf K, Kashima T, Handley VW, McMahon J, Campagnoni AT. Pribyl TM, et al. Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10695-9. doi: 10.1073/pnas.90.22.10695. Proc Natl Acad Sci U S A. 1993. PMID: 7504278 Free PMC article.

Trimolecular interactions in experimental autoimmune demyelinating disease and prospects for immunotherapy - PubMed (original) (raw)